Investors

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Presentations

Egetis’ General Corporate presentation

January 22, 2022

Webcast regarding US regulatory path

January 18, 2022

Webcast regarding marketing authorisation application for Emcitate®

December 13, 2021

Egetis Corporate presentation

November 16, 2021

Redeye life science day

November 11, 2021

Redeye interview with the CEO in connection with the Q3 report

November 4, 2021

Interview with Peder Walberg at Pareto, operative director of the board and founder of Rare Thyroid Therapeutics (in Swedish)

October 28, 2021

Presentation at Penser

30 september, 2021

The Pareto Healthcare conference presentation

September 1, 2021

Corporate presentation

September 1, 2021

Q2 presentation

August 19, 2021

Corporate presentation

July, 2021

ABGSC Life Science Summit

May 25

Erik Penser Bank – Commercialization of pharmaceuticals

May 6, 2021

Aktiedagen (in Swedish)

May 4

Redeye Orphan Drugs

April 28, 2021

Corporate presentation, slides

April 26, 2021

Interview with Dr Thomas Lönngren, nominated CoB and CEO Nicklas Westerholm

April 1, 2021

Egetis – Corporate Presentation

March 5, 2021

Interview with CEO Nicklas Westerholm at Redeye

February 18, 2021

Interview with CEO Nicklas Westerholm in Pareto TV

February 1, 2021

Egetis Therapeutics – Corporate presentation

December, 2020

Company investor and analyst presentation – acquisition of RTT

October 5, 2020

Acquisition of Rare Thyroid Therapeutics – Interview at Redeye

October 5, 2020

Egetis and RTT agree to join forces

October 5, 2020

Pareto Healthcare Seminar – Company presentation

September 2, 2020

 

Calendar and upcoming reports

February 17, 2022
Year-end-report

March 15-17
Carnegie Healthcare Seminar

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com